Tag: FTC pharmaceutical competition
Patent Litigation: How Authorized Generics Undermine Generic Competition
Nov, 27 2025
Authorized generics let brand drug makers launch their own cheaper versions right when independent generics enter the market, undermining price competition and reducing incentives for patent challenges. This practice hurts patients and generic manufacturers - and regulators are fighting back.
Read Article→
online pharmacy
side effects
generic drugs
dosage
counterfeit drugs
medication safety
benefits
pharmacy alternatives
alternatives
family support
Parkinson's disease
motor symptoms
blood sugar control
warfarin
chronic kidney disease
patent litigation
Hatch-Waxman Act
medication side effects
generic substitution
generic vs brand name